Search results
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
Investor's Business Daily· 24 minutes agoGuardant Health stock rocketed Friday after a Food and Drug Administration panel recommended the...
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 4 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
US FDA approves Biocon unit’s biosimilar to blockbuster eye drug Eylea
KFGO· 4 days ago(Reuters) - The U.S. Food and Drug Administration on Monday approved Biocon unit's biosimilar to...
Can You Get Ozempic at Costco? See How to Save on Weight Loss Drugs
Motley Fool via Yahoo Finance· 2 hours agoBut GLP-1 drugs are not cheap. Without insurance, the exact price can range from $950-$1,600 per...
FDA approves CorTec’s implant system for stroke rehabilitation study
Medical Device Network via Yahoo Finance· 4 hours agoPatient enrolment and the inaugural implantation of the neural interfacing system are scheduled for...
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
Terran Biosciences prepares for trials of schizophrenia drug
Clinical Trials Arena via Yahoo Finance· 1 hour agoKarXT was originally developed by Karuna Therapeutics until BMS acquired the company in a $14bn...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
CNN via Yahoo News· 16 hours agoGuardant Health’s Shield tests could be the first approved blood screening test for colorectal...
FDA panel recommends approval of a blood test for colon cancer
NBC NEWS· 16 hours agoAdvisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of...
Panel recommends blood test to detect colon cancer for FDA approval
United Press International via Yahoo News· 13 hours agoA panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new...